Mindy Rabinowitz, MD
Otolaryngology · Wilmington, DENPI 1962727701
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.2%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 53.9% of the total. Reporting peaked in 2022 at $805 and has fallen 59.5% since, to $326 in 2025.
Across 20 payments — averaging $135.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Integra Lifesciences Corporation$426
- Stryker$380
- Regeneron$140
- Sanofi$133
- Acclarent, Inc$84
- plus $85 from 3 others
What the payments were for
- Consulting fees$84031%
- Speaking & faculty fees$40015%
- Food & beverage$1,46654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $1,459 |
| Integra Lifesciences Corporation | 2 | $426 |
| Stryker | 3 | $380 |
| Regeneron | 1 | $140 |
| Sanofi | 1 | $133 |
| Acclarent, Inc | 3 | $84 |
| Neurent Medical Limited | 1 | $43 |
| GSK | 2 | $24 |
| Aerin Medical Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA PADGETT DERMATOMES$400
- SCOPIS ENT$281
- DUPIXENT$273
- NUVENT$250
- PROPEL$164
- FUSION$117
How this compares
$2,706 in reported general payments places this provider in the 70th percentile of 27 otolaryngology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $75,243 |
| Dupixent SyringeDupilumab | 12 | $44,571 |
| Ipratropium Bromide | 157 | $4,466 |
| Mometasone Furoate | 51 | $3,851 |
| Azelastine Hcl | 87 | $1,508 |
| Fluticasone Propionate | 111 | $1,437 |
| Olopatadine Hcl | 14 | $1,112 |
| Montelukast Sodium | 61 | $756 |
| Levocetirizine Dihydrochloride | 26 | $535 |
| Mupirocin | 41 | $429 |
| Minocycline Hcl | 35 | $276 |
| Methylprednisolone | 38 | $194 |
| Doxycycline Monohydrate | 12 | $93 |
| Ciprofloxacin Hcl | 21 | $75 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wilmington
- Paul ImberWilmington$5K
- Udayan ShahWilmington$5K
- Joan CokerWilmington$3K
- Michael TeixidoWilmington$3K
- Neil HocksteinWilmington$2K
- Kieran ConnollyWilmington$2K
- Lauren BogdanWilmington$2K
- Emilio ValdesWilmington$413
- Timoteo GabrielWilmington$157
- James ReillyWilmington$95
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.